STRAUMANN HOLDING AG-REG (QS51.DE) Stock Fundamental Analysis
FRA:QS51 - CH1175448666 - Common Stock
99.14 EUR
+0.56 (+0.57%)
Taking everything into account, QS51 scores 7 out of 10 in our fundamental rating. QS51 was compared to 57 industry peers in the Health Care Equipment & Supplies industry. QS51 has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. QS51 is valied quite expensively at the moment, while it does show a decent growth rate. With these ratings, QS51 could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year QS51 was profitable.
QS51 had a positive operating cash flow in the past year.
In the past 5 years QS51 has always been profitable.
QS51 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 11.23%, QS51 belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
Looking at the Return On Equity, with a value of 19.18%, QS51 belongs to the top of the industry, outperforming 85.96% of the companies in the same industry.
QS51 has a Return On Invested Capital of 20.46%. This is amongst the best in the industry. QS51 outperforms 98.25% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for QS51 is significantly above the industry average of 8.81%.
The last Return On Invested Capital (20.46%) for QS51 is above the 3 year average (19.58%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.23% | ||
| ROE | 19.18% | ||
| ROIC | 20.46% |
ROA(3y)10.34%
ROA(5y)9.59%
ROE(3y)18.64%
ROE(5y)18%
ROIC(3y)19.58%
ROIC(5y)17.81%
1.3 Margins
Looking at the Profit Margin, with a value of 15.29%, QS51 belongs to the top of the industry, outperforming 87.72% of the companies in the same industry.
QS51's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 25.33%, QS51 belongs to the best of the industry, outperforming 91.23% of the companies in the same industry.
QS51's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 71.24%, QS51 belongs to the best of the industry, outperforming 80.70% of the companies in the same industry.
In the last couple of years the Gross Margin of QS51 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.33% | ||
| PM (TTM) | 15.29% | ||
| GM | 71.24% |
OM growth 3Y-1.01%
OM growth 5Y0.13%
PM growth 3Y-7.49%
PM growth 5Y-4.18%
GM growth 3Y-2.13%
GM growth 5Y-1.1%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), QS51 is creating value.
Compared to 1 year ago, QS51 has about the same amount of shares outstanding.
Compared to 5 years ago, QS51 has more shares outstanding
The debt/assets ratio for QS51 has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 8.75 indicates that QS51 is not in any danger for bankruptcy at the moment.
QS51 has a Altman-Z score of 8.75. This is amongst the best in the industry. QS51 outperforms 96.49% of its industry peers.
QS51 has a debt to FCF ratio of 1.43. This is a very positive value and a sign of high solvency as it would only need 1.43 years to pay back of all of its debts.
QS51 has a Debt to FCF ratio of 1.43. This is amongst the best in the industry. QS51 outperforms 87.72% of its industry peers.
QS51 has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
QS51 has a Debt to Equity ratio of 0.10. This is amongst the best in the industry. QS51 outperforms 82.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 1.43 | ||
| Altman-Z | 8.75 |
ROIC/WACC4.12
WACC4.97%
2.3 Liquidity
A Current Ratio of 1.64 indicates that QS51 should not have too much problems paying its short term obligations.
QS51 has a Current ratio (1.64) which is in line with its industry peers.
QS51 has a Quick Ratio of 1.13. This is a normal value and indicates that QS51 is financially healthy and should not expect problems in meeting its short term obligations.
QS51's Quick ratio of 1.13 is in line compared to the rest of the industry. QS51 outperforms 52.63% of its industry peers.
The current and quick ratio evaluation for QS51 is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.64 | ||
| Quick Ratio | 1.13 |
3. Growth
3.1 Past
QS51 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.56%.
QS51 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.26% yearly.
The Revenue has been growing slightly by 7.18% in the past year.
Measured over the past years, QS51 shows a quite strong growth in Revenue. The Revenue has been growing by 9.42% on average per year.
EPS 1Y (TTM)-14.56%
EPS 3Y-1.14%
EPS 5Y5.26%
EPS Q2Q%-5.68%
Revenue 1Y (TTM)7.18%
Revenue growth 3Y7.39%
Revenue growth 5Y9.42%
Sales Q2Q%5.89%
3.2 Future
QS51 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.24% yearly.
Based on estimates for the next years, QS51 will show a quite strong growth in Revenue. The Revenue will grow by 9.57% on average per year.
EPS Next Y19.24%
EPS Next 2Y17.6%
EPS Next 3Y16.94%
EPS Next 5Y17.24%
Revenue Next Year6.48%
Revenue Next 2Y8.02%
Revenue Next 3Y8.53%
Revenue Next 5Y9.57%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
QS51 is valuated quite expensively with a Price/Earnings ratio of 35.16.
QS51's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 26.84. QS51 is valued slightly more expensive when compared to this.
A Price/Forward Earnings ratio of 24.53 indicates a rather expensive valuation of QS51.
QS51's Price/Forward Earnings is on the same level as the industry average.
QS51 is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.48, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.16 | ||
| Fwd PE | 24.53 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as QS51.
QS51's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 48.84 | ||
| EV/EBITDA | 18.38 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
QS51 has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as QS51's earnings are expected to grow with 16.94% in the coming years.
PEG (NY)1.83
PEG (5Y)6.68
EPS Next 2Y17.6%
EPS Next 3Y16.94%
5. Dividend
5.1 Amount
QS51 has a Yearly Dividend Yield of 1.00%. Purely for dividend investing, there may be better candidates out there.
QS51's Dividend Yield is a higher than the industry average which is at 2.32.
Compared to an average S&P500 Dividend Yield of 2.32, QS51's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1% |
5.2 History
The dividend of QS51 is nicely growing with an annual growth rate of 10.12%!
Dividend Growth(5Y)10.12%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
QS51 pays out 38.37% of its income as dividend. This is a sustainable payout ratio.
QS51's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP38.37%
EPS Next 2Y17.6%
EPS Next 3Y16.94%
FRA:QS51 (9/3/2025, 7:00:00 PM)
99.14
+0.56 (+0.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners38.22%
Inst Owner ChangeN/A
Ins Owners32.32%
Ins Owner ChangeN/A
Market Cap15.81B
Analysts73.33
Price Target138.97 (40.18%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1% |
Yearly Dividend0.91
Dividend Growth(5Y)10.12%
DP38.37%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.71%
PT rev (3m)-3.28%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.44%
EPS NY rev (3m)-9.44%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.06%
Revenue NY rev (3m)-1.85%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.16 | ||
| Fwd PE | 24.53 | ||
| P/S | 5.75 | ||
| P/FCF | 48.84 | ||
| P/OCF | 29.63 | ||
| P/B | 7.21 | ||
| P/tB | 12.4 | ||
| EV/EBITDA | 18.38 |
EPS(TTM)2.82
EY2.84%
EPS(NY)4.04
Fwd EY4.08%
FCF(TTM)2.03
FCFY2.05%
OCF(TTM)3.35
OCFY3.37%
SpS17.25
BVpS13.76
TBVpS8
PEG (NY)1.83
PEG (5Y)6.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.23% | ||
| ROE | 19.18% | ||
| ROCE | 24.94% | ||
| ROIC | 20.46% | ||
| ROICexc | 23.47% | ||
| ROICexgc | 37.67% | ||
| OM | 25.33% | ||
| PM (TTM) | 15.29% | ||
| GM | 71.24% | ||
| FCFM | 11.77% |
ROA(3y)10.34%
ROA(5y)9.59%
ROE(3y)18.64%
ROE(5y)18%
ROIC(3y)19.58%
ROIC(5y)17.81%
ROICexc(3y)24.47%
ROICexc(5y)23.84%
ROICexgc(3y)42.44%
ROICexgc(5y)41.27%
ROCE(3y)23.86%
ROCE(5y)21.7%
ROICexcg growth 3Y-8.65%
ROICexcg growth 5Y-1.8%
ROICexc growth 3Y-7.31%
ROICexc growth 5Y1.25%
OM growth 3Y-1.01%
OM growth 5Y0.13%
PM growth 3Y-7.49%
PM growth 5Y-4.18%
GM growth 3Y-2.13%
GM growth 5Y-1.1%
F-Score7
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 1.43 | ||
| Debt/EBITDA | 0.25 | ||
| Cap/Depr | 128.05% | ||
| Cap/Sales | 7.63% | ||
| Interest Coverage | 44.11 | ||
| Cash Conversion | 61.99% | ||
| Profit Quality | 76.93% | ||
| Current Ratio | 1.64 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 8.75 |
F-Score7
WACC4.97%
ROIC/WACC4.12
Cap/Depr(3y)127.11%
Cap/Depr(5y)116.21%
Cap/Sales(3y)7.81%
Cap/Sales(5y)7.04%
Profit Quality(3y)86.54%
Profit Quality(5y)138.64%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.56%
EPS 3Y-1.14%
EPS 5Y5.26%
EPS Q2Q%-5.68%
EPS Next Y19.24%
EPS Next 2Y17.6%
EPS Next 3Y16.94%
EPS Next 5Y17.24%
Revenue 1Y (TTM)7.18%
Revenue growth 3Y7.39%
Revenue growth 5Y9.42%
Sales Q2Q%5.89%
Revenue Next Year6.48%
Revenue Next 2Y8.02%
Revenue Next 3Y8.53%
Revenue Next 5Y9.57%
EBIT growth 1Y0.07%
EBIT growth 3Y6.31%
EBIT growth 5Y9.56%
EBIT Next Year31.64%
EBIT Next 3Y18.52%
EBIT Next 5Y16.75%
FCF growth 1Y20.16%
FCF growth 3Y-10.44%
FCF growth 5Y6.66%
OCF growth 1Y12.05%
OCF growth 3Y-4.8%
OCF growth 5Y5.01%